Clinical Trial

Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches

Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-12-31 -> 2026-12-31 2026-08-14
minor Completion pushed: 2026-06-30 -> 2027-06-30 2026-08-14
Trial Details
NCT Number NCT05679518
Lead Sponsor The University of Hong Kong
Collaborators: Research Grants Council, Hong Kong
Conditions Advanced or Metastatic Cancer, Fear of Cancer Progression, Metacognition-based Intervention, Supportive-expressive Based Intervention, Psychooncology
Enrollment 284 participants
Start Date 2023-12-20
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13